An owl butterfly is not speedy in flight, but the sight of its wings makes creatures think twice about making it a quick meal. The wing pattern resembles the eye of an owl. This ability to mimic a top ...

(Reuters) -Novo Nordisk signed a research tie-up with U.S. biotech firm Metaphore on Thursday to develop next-generation obesity drugs. WHY IT'S IMPORTANT Danish drugmaker Novo is trying to expand ...

The company's MIMiC™ platform drives unprecedented insights into molecular interactions to design new biomolecules precisely tuned for therapeutic benefit With $50 million in committed capital from ...

CAMBRIDGE, Mass., Sept. 9, 2025 /PRNewswire/ -- Metaphore Biotechnologies, a Flagship Pioneering-founded generative AI drug design company focused on creating a new class of functional antibodies, ...

After two years of development at Flagship Pioneering, start-up Metaphore Biotechnologies emerged on May 16 with $50 million of series A funding. It plans to tackle autoimmune and metabolic diseases ...

Metaphore's early pipeline will be aimed at autoimmune, metabolic and oncology indications. (uba-foto/Getty Images) Owl butterflies amazingly ward off foes by disguising themselves as owls, thanks to ...

Metaphore Biotechnologies will work jointly with Novo Nordisk and Pioneering Medicines, Flagship’s in-house drug development and partnerships arm. (Novo Nordisk) In its ongoing mission to find the ...

Last year, Daisuke Kawaguchi began his own personal venture into fashion with his label METAPHORE. Having spent close to a decade working under SOPHNET. and its founder Hirofumi Kiyonaga, we asked ...

Novo in January announced research collaborations with two biotech firms Omega Therapeutics and Cellarity, both of which were founded by U.S. investment firm Flagship Pioneering. Danish drugmaker Novo ...